Sales Director

Cancer care should be more personalized, context-specific, accessible, and human.

Cancer treatment has become extraordinarily complex and precise, but care delivery remains largely episodic. Most of a patient's experience occurs between visits, when symptoms emerge, conditions change and care teams have limited visibility.

This gap is widening, not narrowing. Treatment complexity is growing faster than oncology workforce capacity, advanced therapies once confined to the hospital are increasingly monitored at home, and the cost of that gap is concrete: preventable ED visits, delayed escalation, and clinician burnout from covering more than any single care team can sustainably manage. The problem is not a lack of clinical expertise. It is a lack of infrastructure to extend that expertise continuously, to every patient, between every visit.